Sana Biotechnology

Sana Reports Long-Term Type 1 Diabetes Data

SEATTLE, July 13, 2026 Sana Biotechnology announced the publication of long-term clinical findings in The New England Journal of...

By cGxPwire Editor
July 14, 2026

.Clinical

Sana Biotechnology to Present UP421 Clinical Data at EASD 2026

SEATTLE, July 1, 2026 Sana Biotechnology, Inc. announced that new clinical data from a first-in-human investigator-sponsored study evaluating UP421,...

By cGxPwire Editor
July 6, 2026

Bio-Pharma

Sana Biotechnology Advances In Vivo CAR T Platform

SEATTLE, May 12, 2026 Sana Biotechnology announced new preclinical findings at the 2026 American Society of Gene & Cell...

By cGxPwire Editor
May 14, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Sana Biotechnology

Sana Reports Long-Term Type 1 Diabetes Data

Sana Biotechnology to Present UP421 Clinical Data at EASD 2026

Sana Biotechnology Advances In Vivo CAR T Platform